Romlusevimab Antibody
Romlusevimab (BRII-198) is a recombinant human monoclonal antibody designed for research on SARS-CoV-2. It binds to the viral spike protein, exhibiting neutralizing activity in vitro. This makes it a tool for investigating COVID-19 mechanisms and potential therapeutic applications in preclinical studies.
Product Specifications
Product Name Alternative
BRII198, BRII-198
Target
SARS-CoV
Clonality
Recombinant
Conjugation
Unconjugated
Field of Research
Infectious Disease & Virology
Concentration
14.09 mg/mL
Purity
100.00% (May vary between batches)
Molecular Weight
143.4 kDa
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
GTR15252268 1 Vial
Lentiviral mouse Fgf7 shRNA (UAS) - Lentiviral mouse Fgf7 shRNA (UAS, iRFP) plasmid
Sign In for Pricing
View Details 
MBS6330776-01 0.1 mL
PAQR3, CT (PAQR3, Progestin and adipoQ receptor family member 3, Progestin and adipoQ receptor family member III, Raf kinase trapping to Golgi) (MaxLight 550)
Sign In for Pricing
View Details MBS6330776-02 5x 0.1 mL
PAQR3, CT (PAQR3, Progestin and adipoQ receptor family member 3, Progestin and adipoQ receptor family member III, Raf kinase trapping to Golgi) (MaxLight 550)
Sign In for Pricing
View Details